Trial Profile
Growth and the effect of Genotropin in chronically ill children with juvenile rheumatoid arthritis and with Crohn's disease.
Status:
Discontinued
Phase of Trial:
Phase II/III
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Somatropin (Primary)
- Indications Crohn's disease; Juvenile rheumatoid arthritis
- Focus Therapeutic Use
- 18 Nov 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 05 Oct 2009 New trial record.